+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07313527

Monitoring Aspergillus Fumigatus PCR in Blood and Lung Fluid to Predict Outcomes in Invasive Aspergillosis Adults

Led by University Hospital, Strasbourg, France · Updated on 2026-01-02

100

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying invasive pulmonary aspergillosis, a serious fungal infection, by evaluating the prognostic value of Aspergillus fumigatus PCR levels in blood and bronchoalveolar lavage fluid. The focus is on how variations in PCR levels during antifungal treatment might relate to treatment effectiveness and disease progression, as current data on this topic are limited. This observational study involves patients diagnosed with invasive aspergillosis who have a positive Aspergillus fumigatus PCR test. The PCR tests are used to monitor fungal load and disease stage but no specific treatments or interventions are assigned by the study since it observes existing clinical care. Participants will be followed to assess outcomes such as death rate at day 30 after starting antifungal treatment, particularly in those with positive follow-up PCR tests. The study collects PCR results and clinical data over time to understand correlations with treatment outcomes. Participation duration and exact monitoring schedules vary based on patient care but include regular PCR assessments and clinical follow-up.

CONDITIONS

Brief Title

PCR for Aspergillus Fumigatus in Blood and Bronchoalveolar Lavage Fluid for Monitoring Cases of Invasive Aspergillosis: What is Its Prognostic Value

Research Team

B

baptiste Hoellinger, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here